Evidence map›Paper›PMID 31311181›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Biological Responses of Onion-Shaped Carbon Nanoparticles.

Jaehee Jang, Youngjun Kim, Jangsun Hwang, Yonghyun Choi, Masayoshi Tanaka, Eunah Kang, Jonghoon Choi

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Biocompatibility of nanomaterials and their immunological properties.Biomedical materials (Bristol, England) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jaehee JangSchool of Integrative Engineering, Chung-Ang University, Seoul 06974, Korea.
Youngjun KimSchool of Chemical Engineering & Material Science, Chung-Ang University, Seoul 06974, Korea.
Jangsun HwangSchool of Integrative Engineering, Chung-Ang University, Seoul 06974, Korea.
Yonghyun ChoiSchool of Integrative Engineering, Chung-Ang University, Seoul 06974, Korea.
Masayoshi TanakaDepartment of Chemical Science and Engineering, Tokyo Institute of Technology, Tokyo 152-8550, Japan.ORCID 0000-0002-4701-5352
Eunah KangSchool of Chemical Engineering & Material Science, Chung-Ang University, Seoul 06974, Korea. eakangek@cau.ac.kr.
Jonghoon ChoiSchool of Integrative Engineering, Chung-Ang University, Seoul 06974, Korea. nanomed@cau.ac.kr.ORCID 0000-0003-3554-7033
Chung-Ang University · KRTokyo Institute of Technology · JP

Funding

Chung-Ang University Chung-Ang University grant 2019National Research Foundation of Korea 2017M3A7B8061942
6 · The paper itself

Abstract

Nanodiamonds are emerging as new nanoscale materials because of their chemical stability, excellent crystallinity, and unique optical properties. In this study, the structure of nanodiamonds was engineered to produce carbon nano-onion particles (CNOs) with multiple layers. Following a series of physicochemical characterizations of the CNOs, various evaluations for biological responses were conducted for potential biotechnological applications of the CNOs. The possibility of biological applications was first confirmed by assessment of toxicity to animal cells, evaluation of hemolysis reactions, and evaluation of reactive oxygen species. In addition, human immune cells were evaluated for any possible induction of an immune response by CNOs. Finally, the toxicity of CNOs to

Indexed as

biological propertiescarbon nanomaterialcytotoxicityimmune responsesnano-onion

Identifiers

PMID31311181
PMCPMC6669643
OpenAlexW2956574089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.